iTeos Therapeutics Ownership 2024 | Who Owns iTeos Therapeutics Now?
Institutional Ownership
10.29%
Insider Ownership
0.70%
Retail Ownership
89.01%
Institutional Holders
46.00
iTeos Therapeutics Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BLACKROCK INC. | 10.41% | 0.00% | 3,731,036 | -383,784 | -9.33% | 55,368,573 | Jun 30, 2024 |
| RA CAPITAL MANAGEMENT, L.P. | 9.81% | 0.69% | 3,517,259 | -900,000 | -20.37% | 52,196,124 | Jun 30, 2024 |
| ECOR1 CAPITAL, LLC | 9.07% | 1.48% | 3,249,835 | 1,250,586 | 62.55% | 48,227,551 | Jun 30, 2024 |
| BOXER CAPITAL, LLC | 8.22% | 2.30% | 2,946,915 | 1,142,857 | 63.35% | 43,732,219 | Jun 30, 2024 |
| MPM ASSET MANAGEMENT LLC | 7.64% | 22.32% | 2,738,785 | - | - | 40,643,569 | Jun 30, 2024 |
| VANGUARD GROUP INC | 5.72% | 0.00% | 2,050,006 | 549,404 | 36.61% | 30,422,090 | Jun 30, 2024 |
| VESTAL POINT CAPITAL, LP | 4.88% | 1.94% | 1,750,000 | 1,750,000 | 100.00% | 25,970,000 | Jun 30, 2024 |
| BIOIMPACT CAPITAL LLC | 4.87% | 4.03% | 1,745,943 | - | - | 25,909,794 | Jun 30, 2024 |
| 683 CAPITAL MANAGEMENT, LLC | 3.11% | 1.25% | 1,115,000 | 400,000 | 55.94% | 16,546,599 | Jun 30, 2024 |
| MORGAN STANLEY | 3.04% | 0.00% | 1,089,299 | -543,057 | -33.27% | 16,165,197 | Jun 30, 2024 |
| STATE STREET CORP | 2.69% | 0.00% | 963,901 | 386,356 | 66.90% | 14,304,291,000 | Jun 30, 2024 |
| DIMENSIONAL FUND ADVISORS LP | 2.53% | 0.00% | 908,329 | 117,159 | 14.81% | 13,480,708 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 2.04% | 0.00% | 732,272 | 16,015 | 2.24% | 10,866,917 | Jun 30, 2024 |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2.02% | 0.18% | 723,000 | - | - | 10,729,320 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.73% | 0.00% | 620,258 | 36,738 | 6.30% | 9,207,091 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 1.56% | 0.01% | 559,600 | -157,700 | -21.99% | 8,304,464 | Jun 30, 2024 |
| CANDRIAM S.C.A. | 1.42% | 0.05% | 509,303 | 509,303 | 100.00% | 7,557,704 | Jun 30, 2024 |
| JPMORGAN CHASE & CO | 1.29% | 0.00% | 461,951 | 444,193 | 2501.37% | 6,855,353 | Jun 30, 2024 |
| K2 PRINCIPAL FUND, L.P. | 1.26% | 1.24% | 450,000 | 418,600 | 1333.12% | 6,678,000 | Jun 30, 2024 |
| SATURN V CAPITAL MANAGEMENT LLC | 1.03% | 2.06% | 367,429 | -19,666 | -5.08% | 5,452,646 | Jun 30, 2024 |
iTeos Therapeutics's largest institutional shareholder is BLACKROCK INC., holding 10.41% of the company's total share outstanding, currently valued at $55.37M. The top 10 institutional shareholders own together 66.77% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 7.64% | 22.32% | 2,738,785 | - | - | 40,643,569 | Jun 30, 2024 |
| BIOIMPACT CAPITAL LLC | 4.87% | 4.03% | 1,745,943 | - | - | 25,909,794 | Jun 30, 2024 |
| BOXER CAPITAL, LLC | 8.22% | 2.30% | 2,946,915 | 1,142,857 | 63.35% | 43,732,219 | Jun 30, 2024 |
| SATURN V CAPITAL MANAGEMENT LLC | 1.03% | 2.06% | 367,429 | -19,666 | -5.08% | 5,452,646 | Jun 30, 2024 |
| VESTAL POINT CAPITAL, LP | 4.88% | 1.94% | 1,750,000 | 1,750,000 | 100.00% | 25,970,000 | Jun 30, 2024 |
| ECOR1 CAPITAL, LLC | 9.07% | 1.48% | 3,249,835 | 1,250,586 | 62.55% | 48,227,551 | Jun 30, 2024 |
| 683 CAPITAL MANAGEMENT, LLC | 3.11% | 1.25% | 1,115,000 | 400,000 | 55.94% | 16,546,599 | Jun 30, 2024 |
| K2 PRINCIPAL FUND, L.P. | 1.26% | 1.24% | 450,000 | 418,600 | 1333.12% | 6,678,000 | Jun 30, 2024 |
| K2 PRINCIPAL FUND, L.P. | 0.72% | 0.71% | 257,080 | 237,080 | 1185.40% | 3,815,067 | Jun 30, 2024 |
| RA CAPITAL MANAGEMENT, L.P. | 9.81% | 0.69% | 3,517,259 | -900,000 | -20.37% | 52,196,124 | Jun 30, 2024 |
| SECTORAL ASSET MANAGEMENT INC | 0.27% | 0.58% | 96,966 | -37,000 | -27.62% | 1,438,975 | Jun 30, 2024 |
| DAFNA CAPITAL MANAGEMENT LLC | 0.40% | 0.51% | 144,360 | 45,800 | 46.47% | 2,142,302 | Jun 30, 2024 |
| IKARIAN CAPITAL, LLC | 0.22% | 0.20% | 78,574 | -22,751 | -22.45% | 1,166,038 | Jun 30, 2024 |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2.02% | 0.18% | 723,000 | - | - | 10,729,320 | Jun 30, 2024 |
| ADAR1 CAPITAL MANAGEMENT, LLC | 0.17% | 0.17% | 60,000 | 60,000 | 100.00% | 890,400 | Jun 30, 2024 |
| ALGERT GLOBAL LLC | 0.37% | 0.07% | 133,409 | 6,139 | 4.82% | 1,980,000 | Jun 30, 2024 |
| CLEARLINE CAPITAL LP | 0.44% | 0.06% | 156,894 | 156,894 | 100.00% | 2,328,307 | Jun 30, 2024 |
| SUSQUEHANNA PORTFOLIO STRATEGIES, LLC | 0.28% | 0.06% | 101,775 | - | - | 1,510,341 | Jun 30, 2024 |
| KENNEDY CAPITAL MANAGEMENT LLC | 0.42% | 0.05% | 150,250 | 4,516 | 3.10% | 2,229,710 | Jun 30, 2024 |
| CANDRIAM S.C.A. | 1.42% | 0.05% | 509,303 | 509,303 | 100.00% | 7,557,704 | Jun 30, 2024 |
The largest iTeos Therapeutics shareholder by % of total assets is MPM ASSET MANAGEMENT LLC. The company owns 2.74M shares of iTeos Therapeutics (ITOS), representing 22.32% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| VESTAL POINT CAPITAL, LP | 4.88% | 1.94% | 1,750,000 | 1,750,000 | 100.00% | 25,970,000 | Jun 30, 2024 |
| ECOR1 CAPITAL, LLC | 9.07% | 1.48% | 3,249,835 | 1,250,586 | 62.55% | 48,227,551 | Jun 30, 2024 |
| BOXER CAPITAL, LLC | 8.22% | 2.30% | 2,946,915 | 1,142,857 | 63.35% | 43,732,219 | Jun 30, 2024 |
| VANGUARD GROUP INC | 5.72% | 0.00% | 2,050,006 | 549,404 | 36.61% | 30,422,090 | Jun 30, 2024 |
| CANDRIAM S.C.A. | 1.42% | 0.05% | 509,303 | 509,303 | 100.00% | 7,557,704 | Jun 30, 2024 |
| JPMORGAN CHASE & CO | 1.29% | 0.00% | 461,951 | 444,193 | 2501.37% | 6,855,353 | Jun 30, 2024 |
| K2 PRINCIPAL FUND, L.P. | 1.26% | 1.24% | 450,000 | 418,600 | 1333.12% | 6,678,000 | Jun 30, 2024 |
| 683 CAPITAL MANAGEMENT, LLC | 3.11% | 1.25% | 1,115,000 | 400,000 | 55.94% | 16,546,599 | Jun 30, 2024 |
| STATE STREET CORP | 2.69% | 0.00% | 963,901 | 386,356 | 66.90% | 14,304,291,000 | Jun 30, 2024 |
| K2 PRINCIPAL FUND, L.P. | 0.72% | 0.71% | 257,080 | 237,080 | 1185.40% | 3,815,067 | Jun 30, 2024 |
| CLEARLINE CAPITAL LP | 0.44% | 0.06% | 156,894 | 156,894 | 100.00% | 2,328,307 | Jun 30, 2024 |
| DIMENSIONAL FUND ADVISORS LP | 2.53% | 0.00% | 908,329 | 117,159 | 14.81% | 13,480,708 | Jun 30, 2024 |
| D. E. SHAW & CO., INC. | 0.61% | 0.00% | 219,323 | 82,603 | 60.42% | 3,254,753 | Jun 30, 2024 |
| ADAR1 CAPITAL MANAGEMENT, LLC | 0.17% | 0.17% | 60,000 | 60,000 | 100.00% | 890,400 | Jun 30, 2024 |
| DAFNA CAPITAL MANAGEMENT LLC | 0.40% | 0.51% | 144,360 | 45,800 | 46.47% | 2,142,302 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.73% | 0.00% | 620,258 | 36,738 | 6.30% | 9,207,091 | Jun 30, 2024 |
| RAFFERTY ASSET MANAGEMENT, LLC | 0.10% | 0.00% | 35,985 | 35,985 | 100.00% | 534,017 | Jun 30, 2024 |
| UBS OCONNOR LLC | 0.10% | 0.03% | 35,323 | 35,323 | 100.00% | 524,193 | Jun 30, 2024 |
| FISHER ASSET MANAGEMENT, LLC | 0.10% | 0.00% | 35,215 | 35,215 | 100.00% | 522,590 | Jun 30, 2024 |
| VERITION FUND MANAGEMENT LLC | 0.09% | 0.00% | 31,714 | 31,714 | 100.00% | 470,636 | Jun 30, 2024 |
As of Jun 30 2024, iTeos Therapeutics's largest institutional buyer is VESTAL POINT CAPITAL, LP. The company purchased 1.75M stocks of ITOS, valued at $25.97M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BRAIDWELL LP | - | - | - | -1,162,374 | -100.00% | - | Jun 30, 2024 |
| RA CAPITAL MANAGEMENT, L.P. | 9.81% | 0.69% | 3,517,259 | -900,000 | -20.37% | 52,196,124 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 0.67% | 0.00% | 241,305 | -641,676 | -72.67% | 3,580,966 | Jun 30, 2024 |
| MORGAN STANLEY | 3.04% | 0.00% | 1,089,299 | -543,057 | -33.27% | 16,165,197 | Jun 30, 2024 |
| BLACKROCK INC. | 10.41% | 0.00% | 3,731,036 | -383,784 | -9.33% | 55,368,573 | Jun 30, 2024 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 0.49% | 0.01% | 176,314 | -328,231 | -65.05% | 2,616,500 | Jun 30, 2024 |
| ACADIAN ASSET MANAGEMENT LLC | - | - | - | -244,712 | -100.00% | - | Jun 30, 2024 |
| BARCLAYS PLC | 0.34% | 0.00% | 122,275 | -224,144 | -64.70% | 1,814,000 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 1.56% | 0.01% | 559,600 | -157,700 | -21.99% | 8,304,464 | Jun 30, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | - | - | - | -103,981 | -100.00% | - | Jun 30, 2024 |
| READYSTATE ASSET MANAGEMENT LP | 0.24% | 0.04% | 86,119 | -100,783 | -53.92% | 1,278,006 | Jun 30, 2024 |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | - | - | - | -75,678 | -100.00% | - | Jun 30, 2024 |
| EAGLE ASSET MANAGEMENT INC | 0.46% | 0.01% | 164,232 | -69,352 | -29.69% | 2,465,122 | Jun 30, 2024 |
| AQR CAPITAL MANAGEMENT LLC | 0.08% | 0.00% | 29,298 | -56,870 | -66.00% | 434,782 | Jun 30, 2024 |
| HRT FINANCIAL LP | - | - | - | -50,936 | -100.00% | - | Jun 30, 2024 |
| SQUAREPOINT OPS LLC | 0.05% | 0.00% | 19,636 | -38,801 | -66.40% | 291,398 | Jun 30, 2024 |
| RUSSELL INVESTMENTS GROUP, LTD. | 0.00% | - | 1,033 | -38,098 | -97.36% | 15,329 | Jun 30, 2024 |
| SECTORAL ASSET MANAGEMENT INC | 0.27% | 0.58% | 96,966 | -37,000 | -27.62% | 1,438,975 | Jun 30, 2024 |
| HSBC HOLDINGS PLC | 0.04% | 0.00% | 12,577 | -29,986 | -70.45% | 190,164 | Jun 30, 2024 |
| UBS GROUP AG | 0.08% | 0.00% | 29,386 | -29,708 | -50.27% | 436,088 | Jun 30, 2024 |
As of Jun 30 2024, iTeos Therapeutics's biggest institutional seller is BRAIDWELL LP. The company sold -1.16M shares of ITOS, valued at -.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| VESTAL POINT CAPITAL, LP | 4.88% | 1.94% | 1,750,000 | 1,750,000 | 100.00% | 25,970,000 | Jun 30, 2024 |
| CANDRIAM S.C.A. | 1.42% | 0.05% | 509,303 | 509,303 | 100.00% | 7,557,704 | Jun 30, 2024 |
| CLEARLINE CAPITAL LP | 0.44% | 0.06% | 156,894 | 156,894 | 100.00% | 2,328,307 | Jun 30, 2024 |
| ADAR1 CAPITAL MANAGEMENT, LLC | 0.17% | 0.17% | 60,000 | 60,000 | 100.00% | 890,400 | Jun 30, 2024 |
| RAFFERTY ASSET MANAGEMENT, LLC | 0.10% | 0.00% | 35,985 | 35,985 | 100.00% | 534,017 | Jun 30, 2024 |
| UBS OCONNOR LLC | 0.10% | 0.03% | 35,323 | 35,323 | 100.00% | 524,193 | Jun 30, 2024 |
| FISHER ASSET MANAGEMENT, LLC | 0.10% | 0.00% | 35,215 | 35,215 | 100.00% | 522,590 | Jun 30, 2024 |
| VERITION FUND MANAGEMENT LLC | 0.09% | 0.00% | 31,714 | 31,714 | 100.00% | 470,636 | Jun 30, 2024 |
| BELVEDERE TRADING LLC | 0.06% | 0.00% | 22,600 | 22,600 | 100.00% | 335,384 | Jun 30, 2024 |
| CAPTION MANAGEMENT, LLC | 0.05% | 0.00% | 19,000 | 19,000 | 100.00% | 281,960 | Jun 30, 2024 |
| BANK OF MONTREAL /CAN/ | 0.05% | 0.00% | 16,485 | 16,485 | 100.00% | 249,253 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.04% | 0.00% | 14,371 | 14,371 | 100.00% | 214,160 | Jun 30, 2024 |
| COREBRIDGE FINANCIAL, INC. | 0.04% | 0.00% | 13,966 | 13,966 | 100.00% | 207,255 | Jun 30, 2024 |
| BELVEDERE TRADING LLC | 0.04% | 0.00% | 13,758 | 13,758 | 100.00% | 204,169 | Jun 30, 2024 |
| PACER ADVISORS, INC. | 0.00% | - | 205 | 205 | 100.00% | 3,042 | Jun 30, 2024 |
| BELVEDERE TRADING LLC | 0.00% | - | 100 | 100 | 100.00% | 1,484 | Jun 30, 2024 |
| SRS CAPITAL ADVISORS, INC. | 0.00% | 0.00% | 95 | 95 | 100.00% | 1,410 | Jun 30, 2024 |
| NISA INVESTMENT ADVISORS, LLC | 0.00% | - | 93 | 93 | 100.00% | 1,380 | Jun 30, 2024 |
| ROTHSCHILD INVESTMENT LLC | - | - | 10 | 10 | 100.00% | 148 | Jun 30, 2024 |
iTeos Therapeutics's largest new institutional shareholder by number of shares is VESTAL POINT CAPITAL, LP, purchased 1.75M shares, valued at $25.97M, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BRAIDWELL LP | - | - | - | -1,162,374 | -100.00% | - | Jun 30, 2024 |
| ACADIAN ASSET MANAGEMENT LLC | - | - | - | -244,712 | -100.00% | - | Jun 30, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | - | - | - | -103,981 | -100.00% | - | Jun 30, 2024 |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | - | - | - | -75,678 | -100.00% | - | Jun 30, 2024 |
| HRT FINANCIAL LP | - | - | - | -50,936 | -100.00% | - | Jun 30, 2024 |
| TREXQUANT INVESTMENT LP | - | - | - | -25,886 | -100.00% | - | Jun 30, 2024 |
| LIGHTHOUSE INVESTMENT PARTNERS, LLC | - | - | - | -24,473 | -100.00% | - | Jun 30, 2024 |
| ALLIANZ ASSET MANAGEMENT GMBH | - | - | - | -20,542 | -100.00% | - | Jun 30, 2024 |
| VOYA INVESTMENT MANAGEMENT LLC | - | - | - | -20,312 | -100.00% | - | Jun 30, 2024 |
| TUDOR INVESTMENT CORP ET AL | - | - | - | -17,635 | -100.00% | - | Jun 30, 2024 |
| PRELUDE CAPITAL MANAGEMENT, LLC | - | - | - | -17,428 | -100.00% | - | Jun 30, 2024 |
| GSA CAPITAL PARTNERS LLP | - | - | - | -15,451 | -100.00% | - | Jun 30, 2024 |
| J. GOLDMAN & CO LP | - | - | - | -15,300 | -100.00% | - | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -12,213 | -100.00% | - | Jun 30, 2024 |
| SG AMERICAS SECURITIES, LLC | - | - | - | -9,614 | -100.00% | - | Jun 30, 2024 |
| GLADIUS CAPITAL MANAGEMENT LP | - | - | - | -3,383 | -100.00% | - | Jun 30, 2024 |
| POINT72 ASIA (SINGAPORE) PTE. LTD. | - | - | - | -1,373 | -100.00% | - | Jun 30, 2024 |
| METROPOLITAN LIFE INSURANCE CO/NY | - | - | - | -1,365 | -100.00% | - | Jun 30, 2024 |
| POINT72 (DIFC) LTD | - | - | - | -1,233 | -100.00% | - | Jun 30, 2024 |
| AVION WEALTH | - | - | - | -103 | -100.00% | - | Jun 30, 2024 |
| NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC | - | - | - | -5 | -100.00% | - | Jun 30, 2024 |
iTeos Therapeutics's largest sold out institutional shareholder by shares sold is BRAIDWELL LP, sold -1.16M shares, valued at -, as of undefined.
iTeos Therapeutics Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| BlackRock Advantage SMID Cap Fund, Inc. | 0.12% | 22,493 | - | - | Mar 28, 2024 |
| TEKLA LIFE SCIENCES INVESTORS | 0.10% | 45,735 | - | - | Mar 31, 2024 |
| SYNTAX ETF TRUST | 0.05% | 1,717 | - | - | Mar 31, 2024 |
| Vericimetry Funds | 0.03% | 3,130 | 2,360 | 306.49% | Mar 31, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.03% | 16,182 | - | - | Mar 31, 2024 |
| VANGUARD ADMIRAL FUNDS | 0.03% | 132,375 | - | - | Feb 29, 2024 |
| BNY MELLON INDEX FUNDS, INC. | 0.03% | 32,616 | - | - | Jan 31, 2024 |
| BRIDGEWAY FUNDS INC | 0.03% | 66,500 | - | - | Mar 28, 2024 |
| BNY MELLON INVESTMENT PORTFOLIOS | 0.02% | 13,362 | - | - | Mar 31, 2024 |
| AB CAP FUND, INC. | 0.02% | 682,952 | - | - | Jan 31, 2024 |
| DEUTSCHE DWS INVESTMENT TRUST | 0.02% | 53,410 | - | - | Jan 31, 2024 |
| Advisors Preferred Trust | 0.01% | 90,973 | - | - | Mar 31, 2024 |
| AMERICAN CENTURY QUANTITATIVE EQUITY FUNDS, INC. | 0.01% | 29,579 | - | - | Mar 31, 2024 |
| PFM Multi-Manager Series Trust | 0.01% | 7,072 | 474 | 7.18% | Dec 31, 2023 |
| BNY Mellon Strategic Funds, Inc. | 0.01% | 18,518 | - | - | Mar 31, 2024 |
| Federated Hermes MDT Series | 0.01% | 18,256 | - | - | Jan 31, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.01% | 44,079 | - | - | Mar 31, 2024 |
| Humankind Benefit Corp | 0.01% | 154 | - | - | Dec 31, 2023 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.01% | 3,453 | - | - | Mar 31, 2024 |
| FORUM FUNDS II | 0.01% | 5,555 | - | - | Jan 31, 2024 |
| FIDELITY COMMONWEALTH TRUST | 0.01% | 17,119 | - | - | Feb 29, 2024 |
| ETFis Series Trust I | 0.01% | 7,619 | 553 | 7.83% | Jan 31, 2024 |
| FIDELITY MT VERNON STREET TRUST | 0.01% | 143,743 | - | - | Feb 29, 2024 |
| EXCHANGE TRADED CONCEPTS TRUST | 0.00% | 28,056 | - | - | Feb 29, 2024 |
| TARGET PORTFOLIO TRUST | 0.00% | 91,200 | -6,400 | -6.56% | Jan 31, 2024 |
| FRANKLIN STRATEGIC SERIES | 0.00% | 36,700 | - | - | Jan 31, 2024 |
| VANGUARD HORIZON FUNDS | 0.00% | 76,718 | - | - | Mar 31, 2024 |
| Nushares ETF Trust | 0.00% | 23,790 | - | - | Jan 31, 2024 |
| VANGUARD INDEX FUNDS | 0.00% | 1,163,857 | -389,667 | -25.08% | Mar 31, 2024 |
| GOLDMAN SACHS VARIABLE INSURANCE TRUST | 0.00% | 10,901 | - | - | Mar 31, 2024 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.00% | 572 | - | - | Mar 31, 2024 |
| ALPS ETF Trust | 0.00% | 27,444 | 2,165 | 8.56% | Feb 29, 2024 |
| FIDELITY SELECT PORTFOLIOS | 0.00% | 139,700 | - | - | Feb 29, 2024 |
| DEUTSCHE DWS VARIABLE SERIES II | 0.00% | 5,136 | - | - | Mar 31, 2024 |
| JAMES ADVANTAGE FUNDS | 0.00% | 3,964 | - | - | Dec 31, 2023 |
| SCHWAB CAPITAL TRUST | 0.00% | 67,012 | -146 | -0.22% | Jan 31, 2024 |
| Federated Hermes Adviser Series | 0.00% | 8,750 | - | - | Mar 31, 2024 |
| Lattice Strategies Trust | 0.00% | 2,091 | - | - | Mar 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 253,568 | -13,337 | -5.00% | Feb 29, 2024 |
| Principal Exchange-Traded Funds | 0.00% | 13,437 | - | - | Mar 31, 2024 |
| AB VARIABLE PRODUCTS SERIES FUND, INC. | 0.00% | 4,978 | - | - | Mar 31, 2024 |
| VANGUARD TAX-MANAGED FUNDS | 0.00% | 214,770 | - | - | Mar 31, 2024 |
| TIMOTHY PLAN | 0.00% | 4,430 | - | - | Mar 31, 2024 |
| MFS VARIABLE INSURANCE TRUST III | 0.00% | 15,356 | -625 | -3.91% | Mar 31, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 2,444 | - | - | Mar 31, 2024 |
| Legg Mason ETF Investment Trust | 0.00% | 1,810 | - | - | Mar 31, 2024 |
| PRAXIS MUTUAL FUNDS | 0.00% | 9,220 | - | - | Dec 31, 2023 |
| GPS Funds I | 0.00% | 4,261 | - | - | Mar 31, 2024 |
| SHELTON FUNDS | 0.00% | 1,290 | - | - | Feb 29, 2024 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 98,965 | 10,396 | 11.74% | Mar 31, 2024 |
| PRUDENTIAL INVESTMENT PORTFOLIOS, INC. | 0.00% | 6,750 | -2,500 | -27.03% | Mar 28, 2024 |
| FIDELITY COVINGTON TRUST | 0.00% | 11,899 | -195 | -1.61% | Jan 31, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 20,107 | -2,077 | -9.36% | Mar 31, 2024 |
| ETF Series Solutions | 0.00% | 13,387 | 2,144 | 19.07% | Feb 29, 2024 |
| STEWARD FUNDS, INC. | 0.00% | 1,460 | - | - | Jan 31, 2024 |
| Dimensional ETF Trust | 0.00% | 260,300 | 66,763 | 34.50% | Jan 31, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 17,123 | -1,385 | -7.48% | Mar 31, 2024 |
| PUTNAM ASSET ALLOCATION FUNDS | 0.00% | 16,720 | -263 | -1.55% | Mar 31, 2024 |
| Janus Detroit Street Trust | 0.00% | 76,042 | - | - | Jan 31, 2024 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 488,517 | 92,607 | 23.39% | Jan 31, 2024 |
| OHIO NATIONAL FUND INC | 0.00% | 9,073 | - | - | Mar 31, 2024 |
| Direxion Shares ETF Trust | 0.00% | 67,014 | - | - | Jan 31, 2024 |
| MASTER INVESTMENT PORTFOLIO | 0.00% | 38,901 | 7,834 | 25.22% | Mar 31, 2024 |
| CLEARWATER INVESTMENT TRUST | 0.00% | 3,800 | - | - | Mar 28, 2024 |
| PRUDENTIAL SERIES FUND | 0.00% | 28,540 | - | - | Mar 28, 2024 |
| INVESCO EXCHANGE-TRADED FUND TRUST | 0.00% | 27,217 | 24 | 0.09% | Jan 31, 2024 |
| VANGUARD WORLD FUND | 0.00% | 79,129 | 400 | 0.51% | Feb 29, 2024 |
| COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 321,746 | 177,700 | 123.36% | Mar 31, 2024 |
| Catholic Responsible Investments Funds | 0.00% | 10,000 | - | - | Jan 31, 2023 |
| Federated Hermes Global Allocation Fund | 0.00% | 2,769 | 2,710 | 4593.22% | Feb 29, 2024 |
| Managed Portfolio Series | 0.00% | 6,219 | - | - | Mar 31, 2024 |
| AMERICAN CENTURY ETF TRUST | 0.00% | 30,226 | 8,167 | 37.02% | Feb 29, 2024 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 1,196 | - | - | Mar 31, 2024 |
| SCHWAB STRATEGIC TRUST | 0.00% | 138,509 | 4,828 | 3.61% | Feb 29, 2024 |
| Mutual of America Variable Insurance Portfolios, Inc. | 0.00% | 169 | -10 | -5.59% | Sep 30, 2023 |
| Global X Funds | 0.00% | 10,236 | - | - | Jan 31, 2024 |
| Dunham Funds | 0.00% | 15,272 | - | - | Jan 31, 2024 |
| THRIVENT SERIES FUND INC | 0.00% | 24,223 | - | - | Mar 28, 2024 |
| Guggenheim Variable Funds Trust | 0.00% | 877 | - | - | Dec 31, 2023 |
| Invesco Exchange-Traded Self-Indexed Fund Trust | 0.00% | 46,013 | - | - | Feb 29, 2024 |
| Voya PARTNERS INC | 0.00% | 15,600 | - | - | Mar 31, 2024 |
| SunAmerica Specialty Series | 0.00% | 88 | - | - | Apr 30, 2021 |
| NORTHERN FUNDS | 0.00% | 22,696 | -1,012 | -4.27% | Mar 28, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.00% | 1,569 | - | - | Mar 31, 2024 |
| TIAA-CREF LIFE FUNDS | 0.00% | 343 | - | - | Mar 31, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 8,000 | - | - | Mar 31, 2024 |
| MUTUAL OF AMERICA INVESTMENT CORP | 0.00% | 4,472 | - | - | Mar 31, 2024 |
| Victory Portfolios II | 0.00% | 5,713 | - | - | Mar 31, 2024 |
| NORTHWESTERN MUTUAL SERIES FUND INC | 0.00% | 10,235 | - | - | Mar 31, 2024 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 20,457 | 14,059 | 219.74% | Feb 29, 2024 |
| HC CAPITAL TRUST | 0.00% | 2,572 | - | - | Mar 31, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 1,639 | 260 | 18.85% | Mar 31, 2024 |
| Goldman Sachs ETF Trust | 0.00% | 7,144 | -5,007 | -41.21% | Feb 29, 2024 |
| iSHARES TRUST | 0.00% | 1,181,123 | -77,677 | -6.17% | Mar 31, 2024 |
| LAZARD FUNDS INC | 0.00% | 2,835 | - | - | Mar 31, 2024 |
| GLENMEDE FUND INC | 0.00% | 593 | - | - | Jan 31, 2024 |
| EQ ADVISORS TRUST | 0.00% | 74,109 | -6,604 | -8.18% | Mar 31, 2024 |
| HARTFORD MUTUAL FUNDS II INC | 0.00% | 9,400 | - | - | Jan 31, 2024 |
| ALLIANZ VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 2,937 | -16,064 | -84.54% | Dec 31, 2023 |
| RYDEX SERIES FUNDS | 0.00% | 226 | -5,562 | -96.10% | Dec 31, 2023 |
iTeos Therapeutics's largest mutual fund holder by % of total assets is "BlackRock Advantage SMID Cap Fund, Inc.", owning 22.49K shares, compromising 0.12% of its total assets.
iTeos Therapeutics Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 46 | -66.18% |
| 31 Mar, 24 | 136 | -0.73% |
| 31 Dec, 23 | 137 | -8.05% |
| 30 Sep, 23 | 149 | 0.68% |
| 30 Jun, 23 | 148 | -3.90% |
| 31 Mar, 23 | 154 | 2.67% |
| 31 Dec, 22 | 150 | 8.70% |
| 30 Sep, 22 | 138 | -12.10% |
| 30 Jun, 22 | 157 | -2.48% |
| 31 Mar, 22 | 161 | 40.00% |
| 31 Dec, 21 | 115 | 53.33% |
| 30 Sep, 21 | 75 | -8.54% |
| 30 Jun, 21 | 82 | 3.80% |
| 31 Mar, 21 | 79 | 12.86% |
| 31 Dec, 20 | 70 | 32.08% |
| 30 Sep, 20 | 53 | - |
As of 30 Jun 24, 46 institutions are holding iTeos Therapeutics's shares, representing a decrease of -66.18% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 3,688,399 | -89.31% |
| 31 Mar, 24 | 34,517,358 | -1.12% |
| 31 Dec, 23 | 34,908,053 | -1.63% |
| 30 Sep, 23 | 35,487,057 | 2.07% |
| 30 Jun, 23 | 34,766,079 | -3.38% |
| 31 Mar, 23 | 35,981,639 | -0.78% |
| 31 Dec, 22 | 36,262,834 | -1.05% |
| 30 Sep, 22 | 36,649,340 | -1.73% |
| 30 Jun, 22 | 37,293,125 | 3.27% |
| 31 Mar, 22 | 36,110,764 | 8.17% |
| 31 Dec, 21 | 33,383,344 | 7.20% |
| 30 Sep, 21 | 31,140,426 | 5.68% |
| 30 Jun, 21 | 29,466,024 | -2.06% |
| 31 Mar, 21 | 30,087,266 | 11.89% |
| 31 Dec, 20 | 26,890,751 | 7.81% |
| 30 Sep, 20 | 24,941,957 | - |
iTeos Therapeutics (ITOS) has 3.69M shares outstanding as of 30 Jun 24, down -89.31% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 10.29% | 0.11% |
| 31 Mar, 24 | 96.31% | 1.01% |
| 31 Dec, 23 | 97.55% | 0.99% |
| 30 Sep, 23 | 99.21% | 1.05% |
| 30 Jun, 23 | 97.34% | 0.96% |
| 31 Mar, 23 | 100.74% | 0.97% |
| 31 Dec, 22 | 102.00% | 0.96% |
| 30 Sep, 22 | 103.02% | 0.94% |
| 30 Jun, 22 | 104.91% | 1.01% |
| 31 Mar, 22 | 101.74% | 1.13% |
| 31 Dec, 21 | 94.89% | 1.21% |
| 30 Sep, 21 | 88.47% | 1.26% |
| 30 Jun, 21 | 83.90% | 1.14% |
| 31 Mar, 21 | 85.75% | 0.70% |
| 31 Dec, 20 | 110.44% | 1.05% |
| 30 Sep, 20 | 102.43% | - |
As of 30 Jun 24, iTeos Therapeutics is held by 10.29% institutional shareholders, representing a 0.11% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 21 | -60.38% |
| 31 Mar, 24 | 53 | -29.33% |
| 31 Dec, 23 | 75 | 2.74% |
| 30 Sep, 23 | 73 | -1.35% |
| 30 Jun, 23 | 74 | 7.25% |
| 31 Mar, 23 | 69 | -5.48% |
| 31 Dec, 22 | 73 | -2.67% |
| 30 Sep, 22 | 75 | -25.74% |
| 30 Jun, 22 | 101 | -0.98% |
| 31 Mar, 22 | 102 | 25.93% |
| 31 Dec, 21 | 81 | 113.16% |
| 30 Sep, 21 | 38 | -25.49% |
| 30 Jun, 21 | 51 | -1.92% |
| 31 Mar, 21 | 52 | 13.04% |
| 31 Dec, 20 | 46 | -13.21% |
| 30 Sep, 20 | 53 | - |
21 institutional shareholders have increased their position in ITOS stock as of 30 Jun 24 compared to 53 in the previous quarter (a -60.38% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 14 | -74.07% |
| 31 Mar, 24 | 54 | 35.00% |
| 31 Dec, 23 | 40 | -14.89% |
| 30 Sep, 23 | 47 | - |
| 30 Jun, 23 | 47 | -16.07% |
| 31 Mar, 23 | 56 | 21.74% |
| 31 Dec, 22 | 46 | 27.78% |
| 30 Sep, 22 | 36 | 16.13% |
| 30 Jun, 22 | 31 | -24.39% |
| 31 Mar, 22 | 41 | 78.26% |
| 31 Dec, 21 | 23 | -4.17% |
| 30 Sep, 21 | 24 | 4.35% |
| 30 Jun, 21 | 23 | 76.92% |
| 31 Mar, 21 | 13 | 18.18% |
| 31 Dec, 20 | 11 | - |
| 30 Sep, 20 | - | - |
14 institutional shareholders have reduced their position in ITOS stock as of 30 Jun 24 compared to 54 in the previous quarter (a -74.07% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 46 | -66.18% | 3,688,399 | -89.31% | 10.29% | 0.11% | 21 | -60.38% | 14 | -74.07% |
| 31 Mar, 24 | 136 | -0.73% | 34,517,358 | -1.12% | 96.31% | 1.01% | 53 | -29.33% | 54 | 35.00% |
| 31 Dec, 23 | 137 | -8.05% | 34,908,053 | -1.63% | 97.55% | 0.99% | 75 | 2.74% | 40 | -14.89% |
| 30 Sep, 23 | 149 | 0.68% | 35,487,057 | 2.07% | 99.21% | 1.05% | 73 | -1.35% | 47 | - |
| 30 Jun, 23 | 148 | -3.90% | 34,766,079 | -3.38% | 97.34% | 0.96% | 74 | 7.25% | 47 | -16.07% |
| 31 Mar, 23 | 154 | 2.67% | 35,981,639 | -0.78% | 100.74% | 0.97% | 69 | -5.48% | 56 | 21.74% |
| 31 Dec, 22 | 150 | 8.70% | 36,262,834 | -1.05% | 102.00% | 0.96% | 73 | -2.67% | 46 | 27.78% |
| 30 Sep, 22 | 138 | -12.10% | 36,649,340 | -1.73% | 103.02% | 0.94% | 75 | -25.74% | 36 | 16.13% |
| 30 Jun, 22 | 157 | -2.48% | 37,293,125 | 3.27% | 104.91% | 1.01% | 101 | -0.98% | 31 | -24.39% |
| 31 Mar, 22 | 161 | 40.00% | 36,110,764 | 8.17% | 101.74% | 1.13% | 102 | 25.93% | 41 | 78.26% |
| 31 Dec, 21 | 115 | 53.33% | 33,383,344 | 7.20% | 94.89% | 1.21% | 81 | 113.16% | 23 | -4.17% |
| 30 Sep, 21 | 75 | -8.54% | 31,140,426 | 5.68% | 88.47% | 1.26% | 38 | -25.49% | 24 | 4.35% |
| 30 Jun, 21 | 82 | 3.80% | 29,466,024 | -2.06% | 83.90% | 1.14% | 51 | -1.92% | 23 | 76.92% |
| 31 Mar, 21 | 79 | 12.86% | 30,087,266 | 11.89% | 85.75% | 0.70% | 52 | 13.04% | 13 | 18.18% |
| 31 Dec, 20 | 70 | 32.08% | 26,890,751 | 7.81% | 110.44% | 1.05% | 46 | -13.21% | 11 | - |
| 30 Sep, 20 | 53 | - | 24,941,957 | - | 102.43% | - | 53 | - | - | - |
iTeos Therapeutics Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
Insider Sells
All Insider Owners Trades
The last insider sell of iTeos Therapeutics's stock was made by Detheux Michel on Aug 09 2024, selling 442,800 shares at $11.58 per share (valued at $5.13M). The last insider buy of ITOS was made by RA CAPITAL MANAGEMENT, L.P. on May 14 2024, buying 5,714,285 shares at - per share (worth $5.71K).
iTeos Therapeutics Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | 2 | 1 | 200.00% |
| Q2 2024 | 11 | 1 | 1100.00% |
| Q1 2024 | 5 | - | - |
| Q4 2023 | 6 | - | - |
| Q3 2023 | - | 3 | - |
| Q2 2023 | 7 | - | - |
| Q1 2023 | 7 | 2 | 350.00% |
| Q2 2022 | 23 | 22 | 104.55% |
| Q1 2022 | 14 | 49 | 28.57% |
| Q4 2021 | 15 | 151 | 9.93% |
| Q3 2021 | 1 | 84 | 1.19% |
| Q2 2021 | 23 | 37 | 62.16% |
| Q1 2021 | 5 | - | - |
| Q4 2020 | 1 | - | - |
| Q3 2020 | 82 | 28 | 292.86% |
2 total buy trades, and 1 total sell trades (buy/sell ratio of 2.00%) were made by iTeos Therapeutics's insiders, as of Q3 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | - | - | - |
| Q2 2024 | 1 | - | - |
| Q1 2024 | - | - | - |
| Q4 2023 | 1 | - | - |
| Q3 2023 | - | 3 | - |
| Q2 2023 | - | - | - |
| Q1 2023 | - | - | - |
| Q2 2022 | - | 15 | - |
| Q1 2022 | 4 | 44 | 9.09% |
| Q4 2021 | - | 133 | - |
| Q3 2021 | - | 80 | - |
| Q2 2021 | 1 | 28 | 3.57% |
| Q1 2021 | - | - | - |
| Q4 2020 | - | - | - |
| Q3 2020 | 24 | - | - |
As of Q3 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of iTeos Therapeutics's stocks.
iTeos Therapeutics Peer Ownership
| Ticker | Company |
|---|---|
| GRCL | Gracell Biotechnologies Inc. |
| SANA | Sana Biotechnology, Inc. |
| KYMR | Kymera Therapeutics, Inc. |
| VECT | VectivBio Holding AG |
| RVMD | Revolution Medicines, Inc. Warrant |
| APLS | Apellis Pharmaceuticals, Inc. |
| TCRX | TScan Therapeutics, Inc. |
| BPMC | Blueprint Medicines Corporation |
| DAWN | Day One Biopharmaceuticals, Inc. |
| ERAS | Erasca, Inc. |
| TERN | Terns Pharmaceuticals, Inc. |
| ANNX | Annexon, Inc. |
| MLTX | MoonLake Immunotherapeutics |
| GLUE | Monte Rosa Therapeutics, Inc. |
| DSGN | Design Therapeutics, Inc. |
| ABOS | Acumen Pharmaceuticals, Inc. |
| AMLX | Amylyx Pharmaceuticals, Inc. |
ITOS Ownership FAQ
Who Owns iTeos Therapeutics?
iTeos Therapeutics is owned by institutional shareholders (10.29%), insiders (0.70%), and public (89.01%). The largest institutional shareholder of iTeos Therapeutics is BLACKROCK INC. (10.41% of total shares) and the top mutual fund owner is BlackRock Advantage SMID Cap Fund, Inc. (0.12% of total shares).
Who are the major institutional shareholders of iTeos Therapeutics?
iTeos Therapeutics's major institutional shareholders are BLACKROCK INC., RA CAPITAL MANAGEMENT, L.P., ECOR1 CAPITAL, LLC, BOXER CAPITAL, LLC, and MPM ASSET MANAGEMENT LLC. The top five shareholders own together 45.15% of the company's share outstanding.
How many iTeos Therapeutics shareholders are there?
As of Jun 2024, there are 46 institutional shareholders of iTeos Therapeutics.
What percentage of iTeos Therapeutics is owned by BLACKROCK INC?
BLACKROCK INC owns 3.73M shares of iTeos Therapeutics, representing 10.41% of the company's total shares outstanding, valued at $55.37M (as of Jun 2024).
What percentage of iTeos Therapeutics is owned by RA CAPITAL MANAGEMENT, L.P?
As of Jun 2024, RA CAPITAL MANAGEMENT, L.P holds 3.52M shares of iTeos Therapeutics (ITOS), compromising 9.81% of the company, valued at $52.2M.
What percentage of iTeos Therapeutics is owned by ECOR1 CAPITAL, LLC?
ECOR1 CAPITAL, LLC is the third largest holder of iTeos Therapeutics. The company owns 3.25M of the company's shares outstanding (worth $48.23M).